Ownership history in B Group, Inc. · 5 quarters on record
This page tracks every 13F SEC filing in which B Group, Inc. reported a position in ADMA BIOLOGICS INC (ADMA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 2,457,542 | +45,000 | +1.9% | 33.10% | $44.8M | $18.24 |
| 2025 Q3 | ADDED | 2,412,542 | +95,000 | +4.1% | 26.02% | $35.4M | $14.66 |
| 2025 Q2 | UNCHANGED | 2,317,542 | — | 0% | 32.48% | $42.2M | $18.21 |
| 2025 Q1 | ADDED | 2,317,542 | +30,000 | +1.3% | 39.39% | $46.0M | $19.84 |
| 2024 Q4 | INITIATED | 2,287,542 | — | — | 23.98% | $39.2M | $17.15 |
As of 2025 Q4 — sorted by position size